Indian Journal of Ophthalmology

REVIEW ARTICLE
Year
: 2021  |  Volume : 69  |  Issue : 3  |  Page : 525--534

Neovascular glaucoma - A review


Sirisha Senthil1, Tanuj Dada2, Taraprasad Das3, Sushmita Kaushik4, George Varghese Puthuran5, Reni Philip6, Padmaja Kumari Rani3, Harsha Rao7, Shaveta Singla1, Lingam Vijaya6 
1 VST Glaucoma Center, L V Prasad Eye Institute, Banjara Hills, Hyderabad, Telangana, India
2 Dr. Rajendra Prasad Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India
3 Srimathi Kanuri Santhamma Centre for Vitreoretinal Diseases, L V Prasad Eye Institute, Hyderabad, Telangana, India
4 Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India
5 Aravind Eye Hospital, Madurai, India
6 Smt Jadhavabai Nathmal Singhvee Glaucoma Services, Sankara Nethralaya, Chennai, Tamil Nadu, India
7 Narayana Nethralaya, Bangalore, Karnataka, India

Correspondence Address:
Dr. Sirisha Senthil
L.V Prasad Eye Institute, Kallam Anji Reddy Campus, L V Prasad Marg, Road No. 2, Banjara Hills, Hyderabad - 500 034, Telangana
India

Neovascular glaucoma (NVG) is a sight-threatening secondary glaucoma characterized by appearance of new vessels over the iris and proliferation of fibrovascular tissue in the anterior chamber angle. Retinal ischemia is the common driving factor and common causes are central retinal vein occlusion, proliferative diabetic retinopathy, and ocular ischemic syndrome. The current rise in the prevalence of NVG is partly related to increase in people with diabetes. A high index of suspicion and a thorough anterior segment evaluation to identify the early new vessels on the iris surface or angle are essential for early diagnosis of NVG. With newer imaging modalities such as the optical coherence tomography angiography and newer treatment options such as the anti-vascular endothelial growth factor, it is possible to detect retinal ischemia early, tailor appropriate treatment, monitor disease progression, and treatment response. The management strategies are aimed at reducing the posterior segment ischemia, reduce the neovascular drive, and control the elevated intraocular pressure. This review summarizes the causes, pathogenesis, and differential diagnoses of NVG, and the management guidelines. We also propose a treatment algorithm of neovascular glaucoma.


How to cite this article:
Senthil S, Dada T, Das T, Kaushik S, Puthuran GV, Philip R, Rani PK, Rao H, Singla S, Vijaya L. Neovascular glaucoma - A review.Indian J Ophthalmol 2021;69:525-534


How to cite this URL:
Senthil S, Dada T, Das T, Kaushik S, Puthuran GV, Philip R, Rani PK, Rao H, Singla S, Vijaya L. Neovascular glaucoma - A review. Indian J Ophthalmol [serial online] 2021 [cited 2021 Apr 11 ];69:525-534
Available from: https://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=3;spage=525;epage=534;aulast=Senthil;type=0